N Engl J Med 374(3):233241 Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nuez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W, Wilk A, Bardaji A, Ingold N, Buchan R, Tayal U, Pascual-Figal DA, de Marvao A, Ahmad M, Garcia-Pinilla JM, Pantazis A, Dominguez F, John BA, ORegan DP, Rosen SD, Prasad SK, Lara-Pezzi E, Provencio M, Lyon AR, Alonso-Pulpon L, Cook SA, DePalma SR, Barton PJR, Aplenc R, Seidman JG, Ky B, Ware JS, Seidman CE (2019) Genetic variants associated with cancer therapy-induced cardiomyopathy
IM-first: NAD+ is usually better as IM
Visit us at Perfect B, 3905 NW 107th Ave, Suite 104, Doral FL 33178 Call or message us at (786) 502-2260
Storage After Reconstitution Refrigerate at 36-46F (2-8C) Keep away from light Use within 28-30 days of reconstitution Never freeze reconstituted sermorelin The peptide remains stable at room temperature for up to 72 hours if needed during travel Administration Protocol Timing Your Injection Sermorelin is most effective when administered at bedtime, approximately 30-60 minutes before sleep
